세계의 의료기기 수탁제조 시장 예측(-2030년) : 기기 유형별, 기기 클래스별, 서비스별

The global medical device contract manufacturing market is projected to reach USD 140.84 billion in 2030 from USD 83.77 billion in 2025, at a CAGR of 10.9% between 2025 and 2030.

Rising technological advancements in medical devices, along with an increasing geriatric population, are expected to drive the market. The market is anticipated to grow due to continuous developments in medical fields such as robotics and minimally invasive surgery, artificial intelligence (AI) in medical devices, telemedicine, and remote patient monitoring. The aging population with a rising need for medical diagnostics further contributes to market growth. However, strict regulatory compliance and complexities in supply chain management are expected to limit market growth to some extent.

"By device type, the drug delivery devices segment is expected to witness the highest CAGR in the medical device contract manufacturing market."

The drug delivery devices segment is anticipated to experience the highest CAGR in the medical device contract manufacturing market from 2025 to 2030. This growth is primarily driven by the escalating demand for targeted, efficient, and patient-centric drug delivery systems. The rising incidence of chronic conditions such as diabetes, cancer, and respiratory diseases has significantly increased the utilization of devices, including inhalers, insulin pens, auto-injectors, and implantable pumps. Pharmaceutical companies are increasingly outsourcing the manufacturing of these intricately designed devices to contract manufacturers, capitalizing on their specialized technical capabilities and optimizing production costs. Furthermore, the ongoing advancements in biologics and the shift toward personalized medicine are propelling the demand for innovative drug delivery mechanisms, thereby intensifying growth in this sector throughout the projected period.

"The device development & manufacturing services segment has accounted for the largest share in the market in 2024, by services."

The device development and manufacturing services segment commands the largest market share within the medical device contract manufacturing sector, primarily due to its integral role in transforming concepts into viable medical devices. Smaller enterprises and mid-sized firms often outsource these services to mitigate costs, accelerate their product timelines, and leverage specialized knowledge and advanced manufacturing techniques. This segment encompasses the entire lifecycle of product development, from initial design and prototyping to large-scale commercialization, rendering it crucial for both emerging and established companies. Furthermore, the escalating demand for sophisticated, high-precision medical instruments-such as minimally invasive surgical devices and wearable health monitoring technologies-has significantly heightened the need for comprehensive manufacturing partnerships, thereby solidifying the preeminence of this segment in the market.

"The Asia Pacific accounted for the largest market share in 2024."

The Asia Pacific (APAC) region is experiencing a significant surge in demand for medical device contract manufacturing services, driven by several key factors. Firstly, the rapid population growth in many countries within this region is creating an increased need for advanced medical solutions. Additionally, there is a growing awareness among healthcare providers and patients about the benefits and functionalities of modern medical devices, which further fuels this demand. The expanding middle class in various Asia Pacific nations is also contributing to this trend, as more consumers gain access to healthcare services and products. As a result of these dynamics, global leaders in the medical device contract manufacturing sector are actively establishing and expanding their operations in the Asia Pacific market. These companies are introducing a variety of cutting-edge medical devices, innovative software solutions, and a diverse range of biocompatible materials tailored to meet the needs of different healthcare settings. In particular, China is set to dominate the APAC medical device contract manufacturing market, and it is projected to capture the largest share in 2024. This growth can be attributed to the increasing prevalence of chronic diseases within the population, alongside greater public and institutional awareness regarding the availability and efficacy of medical devices. As a result, the overall market in the Asia Pacific region has accounted for the largest share in the market, driven by these interconnected trends and the continued evolution of the healthcare landscape.

A breakdown of the primary participants (supply-side) for the medical device contract manufacturing market referred to in this report is provided below:

• By Company Type: Tier 1-45%, Tier 2-20%, and Tier 3-35%
• By Designation: C-level Executives-35%, Directors-25%, and Others-40%
• By Region: North America-40%, Europe-25%, Asia Pacific-20%, Latin America- 10%, Middle East & Africa-5%.

The prominent players in the medical device contract manufacturing market include include Jabil Inc. (US), Flex Ltd. (Singapore), Plexus Corp. (US), Sanmina Corporation (US), Integer Holdings Corporation (US), TE Connectivity Ltd. (Switzerland), Nipro Corporation (Japan), Celestica Inc. (Canada), West Pharmaceutical Services, Inc. (US), Benchmark Electronics Inc. (US), Recipharm AB (Sweden), Gerresheimer AG (Germany), Kimball Electronics Inc. (US), Nortech Systems, Inc. (US), Carclo Plc (UK), Nolato GW, Inc. (US), and the other players are Nemera. (France), Viant Medical Holdings, Inc. (US), Tecomet, Inc. (US), SMC Ltd. (US), Phillips-Medisize Corporation (US), Tessy Plastics Corp. (US), MeHow (China), Tekni-Plex (US), and Peter's Technology (China).

Research Coverage:

The report examines the medical device contract manufacturing market and aims to estimate the market size and future growth potential across various segments, including device type, device class, service, and region. It also features a competitive analysis of major players in the market, highlighting their company profiles, product and service offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall medical device contract manufacturing market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report provides insights into the following pointers:

• Analysis of key drivers (growth in medical devices market in developing countries, adoption of robotics and automation in manufacturing, technological advancements in medical device modalities, impact of industry 4.0 on the medical device industry), restraints (consolidation in medical devices market), opportunities (increasing healthcare expenditure, infrastructure, and awareness in developing economies, rising geriatric population and its associated diseases) and challenges (lack of constant innovation to balance technological capabilities against costs)
• Market Penetration: It includes extensive information on product portfolios offered by the major players in the global medical device contract manufacturing market. The report includes various segments in market device type, class of device, service, and region
• Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global medical device contract manufacturing market.
• Market Development: Thorough knowledge and analysis of the profitable rising markets by device type, class of device, service, and region
• Market Diversification: Comprehensive information about newly launched products and services, expanding markets, current advancements, and investments in the global medical device contract manufacturing market.
• Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of products and services, and capacities of the major competitors in the global medical device contract manufacturing market.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKETS COVERED
  • 1.3.2 INCLUSIONS AND EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
• 1.4 STAKEHOLDERS
• 1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH APPROACH
  • 2.1.1 SECONDARY SOURCES
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY SOURCES
    • 2.1.2.1 Key data from primary sources
    • 2.1.2.2 Key industry insights
• 2.2 MARKET SIZE ESTIMATION
• 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
• 2.4 MARKET SHARE ESTIMATION
• 2.5 STUDY ASSUMPTIONS
• 2.6 RISK ASSESSMENT
• 2.7 LIMITATIONS
  • 2.7.1 METHODOLOGY-RELATED LIMITATIONS
  • 2.7.2 SCOPE-RELATED LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET OVERVIEW
• 4.2 ASIA PACIFIC MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY APPLICATION AND COUNTRY
• 4.3 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: EMERGING ECONOMIES VS. DEVELOPED MARKETS
• 4.4 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
• 4.5 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: REGIONAL MIX

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Growing medical devices market in developing countries
    • 5.2.1.2 Adoption of robotics and automation in manufacturing
    • 5.2.1.3 Technological advancements in medical device modalities
    • 5.2.1.4 Impact of industry 4.0 on medical device industry
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Consolidation in medical devices market
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Increasing healthcare expenditure, infrastructure, and awareness in developing economies
    • 5.2.3.2 Rising geriatric population and increasing incidence of associated diseases
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Lack of constant innovation to balance technological capabilities against costs
• 5.3 INDUSTRY TRENDS
  • 5.3.1 INCREASING CONSOLIDATION OF OEMS AND CONTRACT MANUFACTURERS
  • 5.3.2 GROWING INTEREST OF PRIVATE EQUITY FIRMS IN MEDICAL DEVICE CONTRACT MANUFACTURING
  • 5.3.3 OUTSOURCING OF MEDICAL DEVICE CONTRACT MANUFACTURING SERVICES
  • 5.3.4 INDUSTRY 5.0
• 5.4 TECHNOLOGY ANALYSIS
  • 5.4.1 KEY TECHNOLOGIES
    • 5.4.1.1 Digital transformation
    • 5.4.1.2 Robotics and automation
  • 5.4.2 ADJACENT TECHNOLOGIES
    • 5.4.2.1 Artificial Intelligence
    • 5.4.2.2 Big data
  • 5.4.3 COMPLEMENTARY TECHNOLOGIES
    • 5.4.3.1 5G
• 5.5 PORTER'S FIVE FORCES ANALYSIS
  • 5.5.1 THREAT OF NEW ENTRANTS
  • 5.5.2 THREAT OF SUBSTITUTES
  • 5.5.3 BARGAINING POWER OF SUPPLIERS
  • 5.5.4 BARGAINING POWER OF BUYERS
  • 5.5.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.6 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.6.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.6.2 BUYING CRITERIA
• 5.7 REGULATORY LANDSCAPE
  • 5.7.1 REGULATORY FRAMEWORK
    • 5.7.1.1 North America
      • 5.7.1.1.1 US
      • 5.7.1.1.2 Canada
    • 5.7.1.2 Europe
    • 5.7.1.3 Asia Pacific
      • 5.7.1.3.1 Japan
      • 5.7.1.3.2 China
      • 5.7.1.3.3 India
  • 5.7.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• 5.8 PRICING ANALYSIS
  • 5.8.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER, 2022-2024
  • 5.8.2 AVERAGE SELLING PRICE TREND, BY REGION, 2022-2024
• 5.9 VALUE CHAIN ANALYSIS
• 5.10 KEY CONFERENCES AND EVENTS IN 2025-2026
• 5.11 PATENT ANALYSIS
  • 5.11.1 LIST OF MAJOR PATENTS, 2022-2025
• 5.12 SUPPLY CHAIN ANALYSIS
• 5.13 ECOSYSTEM ANALYSIS
• 5.14 TRADE ANALYSIS
  • 5.14.1 IMPORT DATA FOR HS CODE 9018, 2020-2024
  • 5.14.2 EXPORT DATA FOR HS CODE 9018, 2020-2024
• 5.15 ADJACENT MARKETS FOR MEDICAL DEVICE CONTRACT MANUFACTURING
• 5.16 UNMET NEEDS/END-USER EXPECTATIONS IN MEDICAL DEVICE CONTRACT MANUFACTURING MARKET
• 5.17 IMPACT OF GEN AI IN MEDICAL DEVICE CONTRACT MANUFACTURING MARKET
• 5.18 CASE STUDY ANALYSIS
  • 5.18.1 CASE STUDY 1: JABIL INC. AND HEARTWARE INTERNATIONAL PARTNER TO DEVELOP ADVANCED HEART FAILURE TREATMENT
  • 5.18.2 CASE STUDY 2: FLEX LTD. AND MEDTRONIC COLLABORATE TO DEVELOP THE NEXT-GENERATION INSULIN PUMP
  • 5.18.3 CASE STUDY 3: PLEXUS PARTNERED WITH A START-UP TO DEVELOP A REVOLUTIONARY INSULIN PUMP
• 5.19 INVESTMENT AND FUNDING SCENARIO
• 5.20 IMPACT OF 2025 US TARIFFS-MEDICAL DEVICE CONTRACT MANUFACTURING MARKET
  • 5.20.1 INTRODUCTION
  • 5.20.2 KEY TARIFF RATES
  • 5.20.3 PRICE IMPACT ANALYSIS
  • 5.20.4 IMPACT ON COUNTRIES/REGIONS
    • 5.20.4.1 US
    • 5.20.4.2 Europe
    • 5.20.4.3 APAC
  • 5.20.5 IMPACT ON END-USE INDUSTRIES
    • 5.20.5.1 Diagnostic & Imaging Equipment
    • 5.20.5.2 Surgical Instruments & Implants
    • 5.20.5.3 Point-of-Care & Diagnostic Kits

6 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE

• 6.1 INTRODUCTION
• 6.2 IVD DEVICES
  • 6.2.1 IVD CONSUMABLES
    • 6.2.1.1 Increasing demand for reagents & kits to drive market
  • 6.2.2 IVD EQUIPMENT
    • 6.2.2.1 Advances in life sciences research to support market
• 6.3 DIAGNOSTIC IMAGING DEVICES
  • 6.3.1 ADOPTION OF NEW AND ADVANCED DIAGNOSTIC IMAGING SYSTEMS IN DEVELOPING COUNTRIES TO AUGMENT MARKET
• 6.4 CARDIOVASCULAR DEVICES
  • 6.4.1 RISING PREVALENCE OF CVDS TO PROPEL MARKET
• 6.5 DRUG DELIVERY DEVICES
  • 6.5.1 INFUSION DEVICES & ADMINISTRATION SETS
    • 6.5.1.1 Rising incidence of chronic diseases and number of surgical procedures to fuel market
  • 6.5.2 SYRINGES
    • 6.5.2.1 High cost of safety syringes and increasing incidence of needlestick injuries to hinder market
  • 6.5.3 INHALERS
    • 6.5.3.1 High prevalence of asthma, COPD, and cystic fibrosis to aid market growth
  • 6.5.4 AUTOINJECTORS
    • 6.5.4.1 Rising number of regulatory approvals for new drug therapies and advancements to drive market
  • 6.5.5 PEN INJECTORS
    • 6.5.5.1 Rising prevalence of chronic diseases and growing pipeline of biologics and biosimilars to boost market growth
  • 6.5.6 OTHER DRUG DELIVERY DEVICES
• 6.6 ORTHOPEDIC DEVICES
  • 6.6.1 HIGH PREVALENCE OF ORTHOPEDIC CONDITIONS TO DRIVE MARKET
• 6.7 RESPIRATORY CARE DEVICES
  • 6.7.1 GROWING PREVALENCE OF RESPIRATORY INFECTIONS TO DRIVE MARKET
• 6.8 OPHTHALMOLOGY DEVICES
  • 6.8.1 INCREASING PREVALENCE OF OPHTHALMIC DISEASES TO DRIVE MARKET
• 6.9 SURGICAL DEVICES
  • 6.9.1 INCREASE IN SURGICAL PROCEDURES TO FUEL MARKET
• 6.10 DIABETES CARE DEVICES
  • 6.10.1 RISING PREVALENCE OF DIABETES TO PROPEL MARKET
• 6.11 DENTAL DEVICES
  • 6.11.1 RISING INCIDENCE OF DENTAL DISEASES TO DRIVE MARKET
• 6.12 ENDOSCOPY & LAPAROSCOPY DEVICES
  • 6.12.1 RISING PATIENT PREFERENCE FOR MINIMALLY INVASIVE PROCEDURES TO AUGMENT MARKET
• 6.13 GYNECOLOGY/UROLOGY DEVICES
  • 6.13.1 GROWING AWARENESS AND PREVENTIVE CHECK-UPS FOR LATE-PHASE DIAGNOSIS OF STDS TO PROPEL MARKET
• 6.14 PERSONAL CARE DEVICES
  • 6.14.1 SHIFT IN CONSUMPTION PATTERN TOWARD PREMIUM PERSONAL CARE PRODUCTS TO FUEL MARKET
• 6.15 NEUROLOGY DEVICES
  • 6.15.1 RISING GLOBAL BURDEN OF NEUROLOGICAL DISEASES TO DRIVE MARKET
• 6.16 PATIENT MONITORING DEVICES
  • 6.16.1 GROWING AVAILABILITY OF INTEGRATED MONITORING TECHNOLOGY TO AID MARKET
• 6.17 PATIENT ASSISTIVE DEVICES
  • 6.17.1 RISING GERIATRIC POPULATION TO PROPEL MARKET
• 6.18 OTHER DEVICES

7 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE CLASS

• 7.1 INTRODUCTION
• 7.2 CLASS II MEDICAL DEVICES
  • 7.2.1 HIGH-VOLUME UTILIZATION OF CLASS II MEDICAL DEVICES TO SUPPORT MARKET
• 7.3 CLASS I MEDICAL DEVICES
  • 7.3.1 CLASS I DEVICES HOLD LARGEST SHARE OF ALL APPROVED MEDICAL DEVICES
• 7.4 CLASS III MEDICAL DEVICES
  • 7.4.1 HIGHEST LEVEL OF HEALTH RISKS NECESSITATES STRINGENT OVERSIGHT

8 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE

• 8.1 INTRODUCTION
• 8.2 DEVICE DEVELOPMENT & MANUFACTURING SERVICES
  • 8.2.1 DEVICE & COMPONENT MANUFACTURING SERVICES
    • 8.2.1.1 New aspects, such as robotics and personalized medicine, to necessitate specialized device manufacturing capabilities
  • 8.2.2 PROCESS DEVELOPMENT SERVICES
    • 8.2.2.1 Increased R&D spending and innovation and growing demand for complex products to drive market
  • 8.2.3 DEVICE ENGINEERING SERVICES
    • 8.2.3.1 Complexity of device engineering services to propel segment
• 8.3 QUALITY MANAGEMENT SERVICES
  • 8.3.1 PACKAGING VALIDATION SERVICES
    • 8.3.1.1 Increasing product safety concerns for medical devices to aid market
  • 8.3.2 INSPECTION & TESTING SERVICES
    • 8.3.2.1 Availability of technological expertise in testing services to eliminate large capital and overhead investments
  • 8.3.3 STERILIZATION SERVICES
    • 8.3.3.1 Rising complexity of sterility standards to augment market
• 8.4 PACKAGING & ASSEMBLY SERVICES
  • 8.4.1 PRIMARY & SECONDARY PACKAGING SERVICES
    • 8.4.1.1 Growing concerns for patient safety to aid segment
  • 8.4.2 LABELING SERVICES
    • 8.4.2.1 Export bans and product recalls due to improper labeling to support market
  • 8.4.3 OTHER PACKAGING & ASSEMBLY SERVICES
• 8.5 OTHER SERVICES

9 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY REGION

• 9.1 INTRODUCTION
• 9.2 ASIA PACIFIC
  • 9.2.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 9.2.2 CHINA
    • 9.2.2.1 Low labor costs and rapidly changing healthcare infrastructure to drive market
  • 9.2.3 INDIA
    • 9.2.3.1 Rising contract manufacturing capabilities to support market growth
  • 9.2.4 JAPAN
    • 9.2.4.1 Universal healthcare reimbursement policies to propel market
  • 9.2.5 MALAYSIA
    • 9.2.5.1 Increasing R&D activities and investments by established players to augment market growth
  • 9.2.6 THAILAND
    • 9.2.6.1 Government-supported industrial clustering and export competitiveness to propel market
  • 9.2.7 SOUTH KOREA
    • 9.2.7.1 High-value imports from other countries to offer growth opportunities
  • 9.2.8 AUSTRALIA
    • 9.2.8.1 Government-backed investment in sovereign capability to drive medtech manufacturing growth
  • 9.2.9 PHILIPPINES
    • 9.2.9.1 Skilled labor force and IT-enabled support to drive market growth
  • 9.2.10 SINGAPORE
    • 9.2.10.1 Strong government support and global investments to drive market
  • 9.2.11 NEW ZEALAND
    • 9.2.11.1 Deregulation of therapeutic products unlocking expedited access and export potential
  • 9.2.12 REST OF ASIA PACIFIC
• 9.3 EUROPE
  • 9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 9.3.2 GERMANY
    • 9.3.2.1 Presence of major device manufacturers and high healthcare expenditure to support market growth
  • 9.3.3 UK
    • 9.3.3.1 Rising number of accredited clinical laboratories and hospital laboratories to propel market
  • 9.3.4 FRANCE
    • 9.3.4.1 Increasing government pressure for healthcare cost reduction and budgetary constraints to support market growth
  • 9.3.5 SPAIN
    • 9.3.5.1 Increasing adoption of home-based medical devices to drive market
  • 9.3.6 ITALY
    • 9.3.6.1 Healthcare coverage for all citizens and foreign residents to increase demand for medical devices
  • 9.3.7 REST OF EUROPE
• 9.4 NORTH AMERICA
  • 9.4.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 9.4.2 US
    • 9.4.2.1 Presence of stringent government regulations to drive market
  • 9.4.3 CANADA
    • 9.4.3.1 Strong presence of key contract manufacturing companies to augment market
• 9.5 LATIN AMERICA
  • 9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 9.5.2 BRAZIL
    • 9.5.2.1 Favorable government initiatives and willingness to pay for better healthcare to boost market
  • 9.5.3 MEXICO
    • 9.5.3.1 Proximity to US and other LATAM countries to strengthen Mexico's relevance as a contract manufacturing hub
  • 9.5.4 REST OF LATIN AMERICA
• 9.6 MIDDLE EAST & AFRICA
  • 9.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 9.6.2 GCC COUNTRIES
    • 9.6.2.1 Increasing healthcare infrastructure development to support market growth
    • 9.6.2.2 Kingdom of Saudi Arabia (KSA)
      • 9.6.2.2.1 Focus on healthcare localization and Vision 2030 to drive investment
    • 9.6.2.3 United Arab Emirates (UAE)
      • 9.6.2.3.1 Advanced infrastructure and regulatory efficiency to attract global medtech contract manufacturers
    • 9.6.2.4 Rest of GCC Countries
  • 9.6.3 REST OF MIDDLE EAST AND AFRICA

10 COMPETITIVE LANDSCAPE

• 10.1 OVERVIEW
  • 10.1.1 KEY STRATEGIES ADOPTED BY PLAYERS IN MEDICAL DEVICE CONTRACT MANUFACTURING MARKET
• 10.2 REVENUE ANALYSIS, 2020-2024
• 10.3 MARKET SHARE ANALYSIS, 2024
• 10.4 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
  • 10.4.1 STARS
  • 10.4.2 EMERGING LEADERS
  • 10.4.3 PERVASIVE PLAYERS
  • 10.4.4 PARTICIPANTS
  • 10.4.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
    • 10.4.5.1 Company footprint
    • 10.4.5.2 Region footprint
    • 10.4.5.3 Device footprint
    • 10.4.5.4 Device class footprint
    • 10.4.5.5 Service footprint
• 10.5 COMPANY EVALUATION MATRIX, STARTUPS/SMES, 2024
  • 10.5.1 PROGRESSIVE COMPANIES
  • 10.5.2 RESPONSIVE COMPANIES
  • 10.5.3 DYNAMIC COMPANIES
  • 10.5.4 STARTING BLOCKS
  • 10.5.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
    • 10.5.5.1 Detailed list of key startups/SMEs
    • 10.5.5.2 Competitive benchmarking of key startups/SMEs
• 10.6 COMPANY VALUATION & FINANCIAL METRICS
  • 10.6.1 FINANCIAL METRICS
  • 10.6.2 COMPANY VALUATION
• 10.7 BRAND/PRODUCT COMPARATIVE ANALYSIS
• 10.8 R&D ASSESSMENT OF KEY PLAYERS
• 10.9 COMPETITIVE SCENARIO

11 COMPANY PROFILES

• 11.1 KEY PLAYERS
  • 11.1.1 JABIL INC.
    • 11.1.1.1 Business overview
    • 11.1.1.2 Products/Services/Solutions offered
    • 11.1.1.3 Recent developments
      • 11.1.1.3.1 Product approvals
      • 11.1.1.3.2 Deals
    • 11.1.1.4 MnM view
      • 11.1.1.4.1 Right to win
      • 11.1.1.4.2 Strategic choices made
      • 11.1.1.4.3 Weaknesses and competitive threats
  • 11.1.2 FLEX LTD.
    • 11.1.2.1 Business overview
    • 11.1.2.2 Products/Services/Solutions offered
    • 11.1.2.3 Recent developments
      • 11.1.2.3.1 Deals
    • 11.1.2.4 Expansions
    • 11.1.2.5 MnM view
      • 11.1.2.5.1 Right to win
      • 11.1.2.5.2 Strategic choices made
      • 11.1.2.5.3 Weaknesses and competitive threats
  • 11.1.3 PLEXUS CORP.
    • 11.1.3.1 Business overview
    • 11.1.3.2 Products/Services/Solutions offered
    • 11.1.3.3 Recent developments
      • 11.1.3.3.1 Expansions
    • 11.1.3.4 MnM view
      • 11.1.3.4.1 Right to win
      • 11.1.3.4.2 Strategic choices made
      • 11.1.3.4.3 Weaknesses and competitive threats
  • 11.1.4 SANMINA CORPORATION
    • 11.1.4.1 Business overview
    • 11.1.4.2 Products/Services/Solutions offered
    • 11.1.4.3 Recent developments
      • 11.1.4.3.1 Deals
    • 11.1.4.4 MnM view
      • 11.1.4.4.1 Right to win
      • 11.1.4.4.2 Strategic choices made
      • 11.1.4.4.3 Weaknesses and competitive threats
  • 11.1.5 INTEGER HOLDINGS CORPORATION
    • 11.1.5.1 Business overview
    • 11.1.5.2 Products/Services/Solutions offered
    • 11.1.5.3 Recent developments
    • 11.1.5.4 Deals
    • 11.1.5.5 MnM view
      • 11.1.5.5.1 Right to win
      • 11.1.5.5.2 Strategic choices made
      • 11.1.5.5.3 Weaknesses and competitive threats
  • 11.1.6 TE CONNECTIVITY LTD.
    • 11.1.6.1 Business overview
    • 11.1.6.2 Products/Services/Solutions offered
    • 11.1.6.3 Recent developments
      • 11.1.6.3.1 Product launches
    • 11.1.6.4 Deals
  • 11.1.7 NIPRO CORPORATION
    • 11.1.7.1 Business overview
    • 11.1.7.2 Products/Services/Solutions offered
    • 11.1.7.3 Recent developments
      • 11.1.7.3.1 Expansions
  • 11.1.8 CELESTICA INC.
    • 11.1.8.1 Business overview
    • 11.1.8.2 Products/Services/Solutions offered
    • 11.1.8.3 Recent developments
      • 11.1.8.3.1 Expansions
      • 11.1.8.3.2 Other developments
  • 11.1.9 WEST PHARMACEUTICAL SERVICES, INC.
    • 11.1.9.1 Business overview
    • 11.1.9.2 Products/Services/Solutions offered
    • 11.1.9.3 Recent developments
      • 11.1.9.3.1 Product launches
      • 11.1.9.3.2 Deals
  • 11.1.10 BENCHMARK ELECTRONICS INC.
    • 11.1.10.1 Business overview
    • 11.1.10.2 Products/Services/Solutions offered
    • 11.1.10.3 Recent developments
      • 11.1.10.3.1 Deals
      • 11.1.10.3.2 Expansions
  • 11.1.11 RECIPHARM AB
    • 11.1.11.1 Business overview
    • 11.1.11.2 Products/Services/Solutions offered
    • 11.1.11.3 Recent developments
      • 11.1.11.3.1 Deals
    • 11.1.11.4 Other developments
  • 11.1.12 GERRESHEIMER AG
    • 11.1.12.1 Business overview
    • 11.1.12.2 Products/Services/Solutions offered
    • 11.1.12.3 Recent developments
      • 11.1.12.3.1 Deals
  • 11.1.13 KIMBALL ELECTRONICS, INC.
    • 11.1.13.1 Business overview
    • 11.1.13.2 Products/Services/Solutions offered
  • 11.1.14 NORTECH SYSTEMS, INC.
    • 11.1.14.1 Business overview
    • 11.1.14.2 Products/Services/Solutions offered
    • 11.1.14.3 Recent developments
      • 11.1.14.3.1 Product approvals
  • 11.1.15 CARCLO PLC
    • 11.1.15.1 Business overview
    • 11.1.15.2 Products/Services/Solutions offered
  • 11.1.16 NOLATO GW, INC. (A PART OF NOLATO AB)
    • 11.1.16.1 Business overview
    • 11.1.16.2 Products/Services/Solutions offered
    • 11.1.16.3 Recent developments
      • 11.1.16.3.1 Deals
• 11.2 OTHER PLAYERS
  • 11.2.1 NEMERA
  • 11.2.2 VIANT MEDICAL HOLDINGS, INC.
  • 11.2.3 TECOMET, INC.
  • 11.2.4 SMC LTD.
  • 11.2.5 PHILLIPS-MEDISIZE CORPORATION
  • 11.2.6 TESSY PLASTICS CORP.
  • 11.2.7 MEHOW
  • 11.2.8 TEKNI-PLEX
  • 11.2.9 PETER'S TECHNOLOGY

12 APPENDIX

• 12.1 DISCUSSION GUIDE
• 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 12.3 CUSTOMIZATION OPTIONS
• 12.4 RELATED REPORTS
• 12.5 AUTHOR DETAILS